Nectar Lifesciences Q3 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
12.23
0.06 (0.49%)
0.06 (0.49%)Volume3.71 K
Updated: Wed 22 Apr, 2026 | 10:16:54
NSE
12.230.06 (0.49%)
0.06 (0.49%)Volume23.69 K
Updated: Wed 22 Apr, 2026 | 10:01:05
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹0.00 Cr.(NA%)
- Operating Profit₹86.16 Cr.(NA%)
- Profit After Tax₹67.63 Cr.(29430.92%)
- Operating MarginNA%(NA%)
Note: Comparison is on YoY basis
Quarterly - Nectar Lifesciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | -86.16 | 6.77 | 0.00% | 425.35 | 0.00% |
| Depreciation/ Amortization | 0.06 | 0.45 | -69.67% | 15.37 | -11.32% |
| Operating Income | 86.16 | -1.04 | 0.00% | 26.82 | 0.00% |
| Net Income | 14.27 | 5.60 | 0.00% | 1.57 | 82.00% |
| Other Operating Expenses Total | 1.32 | 1.72 | -31.97% | 60.99 | 5544.64% |
| Net Income Before Taxes | 56.60 | -0.35 | 0.00% | 2.46 | 15979.80% |
| Total Revenue | 0.00 | 5.73 | 0.00% | 452.17 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.61 | 0.68 | -18.92% | 21.62 | 2262.40% |
| Diluted Normalized EPS | 0.46 | -0.01 | 0.00% | 0.07 | 4432.19% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.